Burzynski Research Institute, Inc. (BZYR)

USD 0.04

(0.0%)

Market Cap (In USD)

4.73 Million

Revenue (In USD)

-

Net Income (In USD)

-1.33 Million

Avg. Volume

5169.00

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.013-0.077
PE
-
EPS
-
Beta Value
1.074
ISIN
US1231591058
CUSIP
123159105
CIK
724445
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Stanislaw R. Burzynski M.D., Ph.D.
Employee Count
-
Website
https://www.burzynskiclinic.com
Ipo Date
1997-01-02
Details
Burzynski Research Institute, Inc. engages in the research and development of antineoplaston drugs to treat cancer. The company is also involved in the production, marketing, promotion, and sale of medical chemical compounds composed of growth-inhibiting peptides, amino acid derivatives, and organic acids under the Antineoplastons trade name. It also offers consulting services. Burzynski Research Institute, Inc. was founded in 1977 and is based in Houston, Texas.